ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables (hass)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01195805
Recruitment Status : Completed
First Posted : September 6, 2010
Last Update Posted : August 20, 2015
Sponsor:
Information provided by (Responsible Party):
Erling Bjerregaard Pedersen, Regional Hospital Holstebro

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2015
  Actual Study Completion Date : August 2015